Tell Eli Lilly: Make insulin affordable!

Pharma company Eli Lilly made $100 million more on Humalog insulin sales to Medicaid in 2016 than in 2015, despite the fact that the product is more than 20 years old.

We’re calling on Eli Lilly to be transparent about its costs and profits, and to lower the price of insulin so that everyday people can afford this life-saving treatment.

Sign below if you’d like to see Eli Lilly clean up its business practices and protect the health of those who depend on the company’s products to live.